SEGALL BRYANT & HAMILL, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1006378 CHICAGO, IL

Position in SUPN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,206,050

+$8,445 QoQ

Shares Held

25,931

+11.9% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#127

of 333 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. SUPN ranks #8 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	498,222	$26,106,832
2	NBIX	Neurocrine Biosciences Inc	64,908	$10,939,594
3	KNSA	Kiniksa Pharmaceuticals International, plc	71,901	$4,598,068
4	AMRX	Amneal Pharmaceuticals, Inc.	240,060	$4,155,438
5	LQDA	Liquidia Corp	50,802	$4,050,443
6	ANIP	Ani Pharmaceuticals Inc	32,860	$2,720,150
7	IRWD	Ironwood Pharmaceuticals Inc	408,064	$1,717,949
8	SUPN	Supernus Pharmaceuticals, Inc. This page	25,931	$1,206,050

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,206,050	25,931	+11.9%	Shares	Sole	2026-08-12
2026-03-31	$1,197,605	23,169	-0.3%	Shares	Sole	2026-05-22
2025-12-31	$1,154,680	23,233	+35.5%	Shares	Sole	2026-02-13
2025-09-30	$819,311	17,144	-27.5%	Shares	Sole	2025-11-12
2025-06-30	$745,448	23,650	-6.6%	Shares	Sole	2025-08-12
2025-03-31	$829,524	25,329	0.0%	Shares	Sole	2025-05-02
2024-12-31	$915,896	25,329	-0.2%	Shares	Sole	2025-02-11
2024-09-30	$791,254	25,377	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.